Vanadium derivatives act as growth factor-mimetic compounds upon differentiation and
proliferation of osteoblast-like UMR106 cells by Cortizo, Ana María & Etcheverry, Susana B.
Molecular and Cellular Biochemistry 145: 97-102, 1995.
@ 1,995 Kluwer Academíc Publíshers. Printed in the Netherlands.
Vanadium derivatives act as growth factor-
mimetic compounds upon differentiation and
proliferation of osteoblast-like UMR106 cells
Ana M. Cortizot and Susana B. Etcheverrlrr'2
tCátedra de Bioquímica Patológica, Facultad de Ciencias Exactas;2Programa QUINOR, Facultad de Cienciqs Exactas,
Universidad Nacional de La Plata, 47 y I I5 (l900) La Plata, Argentina
Received 14May 1994; accepted 2l November 1994
Abstract
The effect of different vanadium compounds on proliferation and differentiation was examined in osteoblast-like UMRl06 cells.
Vanadate increased the cell growth in a biphasic manner, the higher doses inhibiting cell progression. Vanadyl stimulated cell
proliferation in a dose-responsive manner. Similar to vanadate, pervanadate increased osteoblast-like cell proliferation in a biphasic
manner but no inhibition of growth was observed. Vanadyl and pervanadate were stronger stimulators of cell growth than vana-
date. Only vanadate was able to regulate the cell differentiation as measured by cell alkaline phosphatase activity. These results
suggest that vanadium derivatives behave like growth factors on osteoblast-like cells and are potential pharmacological tools in
the control of cell growth. (Mol Cell Biochem 145:97_102,1995)
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Introduction
Osteoblasts are important cells involved in bone formation.
Their activity is regulated by several systemic hormones
(growth hormone, GH; insulin; glucocorticoids; parathyroid
hormone, PTH; vitamin D) and local factors like transform-
ing growth factor (TGF), fibroblast growth factor (FGF),
insulin-like growth factors (lGFs), plateletderived growth
factor (PDGF) Il-31. Systemic hormones can act directly on
the bone or by inducing the secretion ofcytokines and growth
factors [4]. It has been found that human bone cells in cul-
ture produce a number of growth factors, many of which are
known to be stored in human bone, including IGF-1, IGF-Il,
TGF-p and PDGF [5]. The hormonal action is mediated by
cell surface specific receptors identified in osteoblasts in
culture [G{]. On the other hand, several ions (Ca, Zn,p,Mn,
Cu, V) also modulate the activity of the bone cells [9, l0].
Vanadium is an essential nutritional element and its defi-
ciency causes growth inhibition and skeletal deformation in
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animals [10]. Vanadate shows significant biological effects
on bone development lll,12l; it also acts like an insulin-
mimetic factor [3]. Recently, different vanadium com-
pounds, such as pervanadates, have been shown to stimulate
the intracellular levels ofphosphoproteins Il 4-l 6].Although
the intimate molecular mechanism of their action is still un-
known, it is probably mediated by the inhibition of protein
phosphotyrosyl-phosphatases (PTPases) [14, 17]. We have
recently shown that vanadate, vanadyl, peroxo- and hydro-
peroxovanadium compounds selectively inhibit a bone solu-
ble alkaline phosphatase, partially characterized as a PTpase
tl8l.
The aim of the present study was to obtain a deeper insight
into the effects ofvanadium derivatives on the proliferation
and differentiation of osteoblast-like UMRl06 cells in cul-
ture. UMRl06 cells are clonal osteosarcoma cells that have
preserved many different properties of osteoblasts, including
cAMP responsiveness to PTH, high alkaline phosphatase and
synthesis of bone-specific collagen [1 9].
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Materials and methods
Materials
Porcine insulin was obtained from Lilly Co, IGF-l from
Bachem and bovine growth hormone from Wilhelmi. Vana-
dium (lV) oxide sulfate (vanadyl sulfate) was obtained from
Merck, catalase and p-nitrophenylphosphate (pNPP) were
obtained from SIGMA. Tissue culture materials were pro-
vided by Corning or Falcon. Dulbecco's modified Eagle's
medium (DMEM), trypsin, ethylenediamine-tetraacetic acid
(EDTA) were supplied by GIBCO and fetal bovine serum
(FBS) by Gen (Argentina). All other chemicals were of ana-
l¡ical grade from SIGMA. Solutions of vanadate, vanadyl
and peroxoderivates were prepared as previoüsly reported
[8]. In brief, pervanadate was obtained by reaction of
orthovanadate with HrO, at 22"C for l5 min. The excess of
HrO, was removed with catalase.
Cell culture
Rat osteosarcoma cell line UMRI06 was grown in DMEM
supplemented with l0% FBS and antibiotics in a humidified
atmosphere of 95oA airlíYo COr. Cells were grown at near-
confluence (70_{0%) and they were subcultured using 0. l%
trypsin- I mM EDTAin Ca2*- Mgtlfree phosphate-buffered
saline (PBS). For experiments, about 2.5 . lU cells/ml were
plated into 24 welVplates. After the culture reached 70%o con-
fluence, the cells were washed with DMEM without serum and
incubated in 0.5 ml DMEM plus various concentrations of
hormones or different vanadium compounds for 24h.
Cell proliftration assay
A mitogenic bioassay was carried out as described by
Okajima et al. l20l with some modifications. Briefly, cells
in 24 well/plate were washed with PBS and fixed with 5%
glutaraldehyde/PBS at room temperature for l0 min. Cells
were then stained with 0.5% crystal violet/25o6methanol for
l0 min. After that, the dye solution was discarded and the
plate was washed with water and dried. The dye in the cells
was extracted using 0.5 ml/well0.l M glycine/HCl buffer, pH
3.0/30% methanol and transfered to test tubes. Absorbance
was read at 540 nm after a convenient sample dilution. In
order to confirm that the colorimetric bioassay correlated with
cell proliferation, the relationship between cell number/well
and the absorbance at 540 nm of diluted extraction sample
after crystal violet staining of a different set of wells was ex-
amined. Cell number was determined by trypsinization of
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Fig. /. Conelation between the total cell number per well and the optical
density at 540 nm corrected by dilution ofcell extract (crystal violet assay).
l, 3, A values represent three independent experiments performed by
triplicate.
wells and counting with a Neubauer chamber. Figure I dem-
onstrates a strong linear correlation between the total cell
number/well and OD540 corrected by sample dilution over
the range of cell numbers obtained by stimulation with dif-
ferent agents.
Alkaline p ho s p h atas e ac tivi ty
Cells were incubated at 37"C124 h in a serum-free medium
containing different agents. The cell layer was washed with
PBS and solubilized in 0.5 ml0.l% Triton-X100. Aliquots
of the total cell extract ( l0%) were used for protein determi-
nation using the Bio Rad Bradford technique [21] and
1O-20% for measurement of alkaline phosphatase activity.
The enzyme activity was assayed by the hydrolisis of pNPP
to pNP at37"C for 15 min in 20 mM HEPES buffer pH 8.0
in the presence of 20 mM KCI and 30 mM MgClr. The ab-
sorbance at 405 nm was measured as previously described
[ 8]. Alkaline phosphatase activity is known as a marker of
mature osteoblast phenotype and this method has been ex-
tensively used to assess cell differentiation in cell culture
systems f22--251.
Statistical methods
Data are expressed as the mean * SEM. Statistical differences
were analyzed using Student's l-test or analysis ofvariance
when suitable. Linear regression analysis was performed by
the Pearson's correlation coeffrcient.
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0.58 pglml Insulin
0.75 ¡g/ml ICF-I
1.0 Fg/ml bGH
100 + 3.3
140 r2.4#
t3l+2.1*
133 r 3.2*
100 * 6.1
59 + 1.5*
54 + 3.0f
84 13.5
Table L Effect ofgrowth factors on the proliferation and differentiation
of UMRI0ó cells
Addition Proliferation Differentiation
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vanadium compounds acting as growth factors, we evaluated
the effects ofvanadate on cellular proliferation and differen-
tiation. Vanadate stimulated cell proliferation in a biphasic
curye manner, with a maximum obtained at 10-25 ¡rM, but
without further effects (Fig. 2,A). High concentrations of
vanadate induced a small decrease in cell proliferation.
The action of vanadate upon cell differentiation is shown
in a mirror curve with respect to the proliferative effect (Fig.
2B). Maximal inhibition was observed at 5-2.5 ¡rM and stimu-
lation was seen at 75-100 pM. We have previously shown
that vanadate, vanadyl and pervanadate (5-100 pM) directly
inhibit the osteoblast-like cell alkaline phosphatase activity
[8]. Accordingly, the results in Fig. 28 could be explained
by a direct inhibition ofvanadate on alkaline phosphatase.
In order to test this hypothesis, in a new series of experiments,
the assay was performed in the presence of 25 pM EDTA
(Table 2). This reagent strongly complexes vanadate (Ka =
10r5, [26]) which otherwise, could be free in the cell extract
to inhibit alkaline phosphatase. In the presence of EDTA, the
inhibitory effect of vanadate on cell differentiation was re-
produced. These results suggest that the effect ofvanadate
on cell diferentiation, as assessed by alkaline phosphatase
activity, was not a direct in vitro inhibitory effect of vanad-
ate but probably a change in the enzyme content.
Since some cellular types are able to reduce vanadate to
vanadyl, which seems to be the effective mediator, we tested
the effects of vanadyl cation on the UMRl06 cells. Fig.3A
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Cells were exposed to DMEM plus different growth factors for 24 h. Cell
proliferation was measured by the crystal violet bioassay and the cell dif-
ferentiation as alkaline phosphatase activity. Results are expressed as 7o
over basal (non addition), mean t SEM (n = 4). p values vs basal: *p <
0.01 , #p < 0.001 .
Results
The addition of insulin, IGF-I and bovine GH to UMRl06
cells in serum-free media produced a significant increase in
cell proliferation after 24 h of incubation. The same hormo-
nal doses inhibited cellular differentiation measured through
alkaline phosphatase activity (Table l). Insulin and IGF-l
seem to have a similar quantitative effect, while bGH showed
a weak effect under comparative conditions. These results
showed that the growth of osteoblast-like UMRl06 cells is
regulated by different hormones and growth factors.
To determine if the UMR I 06 cells were also modulated by
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Fig' 2. Effect of vanadate on the cell proliferation and differentiation in osteoblastJike UMRl06 cells. Cells were incubated in DMEM plus vanadate at
the doses indicated. After 24 h, cells were washed, fixed and stained with crystal violet to evaluare cell prolileration (A) or solubilized in 0. l% Triton
Xl00 to determine alkaline phosphatase activity (B). Data are expressed asoA over basal and indicate the mean * SEM (n = 9). p values vs basal: o p <
0.05, *p < O.02, #p < 0.001.
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Table 2. Effect of EDTA addition in the alkaline phosphatase assay from
UMRt0ó cells incubated with vanadate
ALP activity [% Basal]
Vanadate
lrrMl _ EDTA
had no action on cell differentiation (Fig. 48) as assayed by
alkaline phosphatase activity. These results are in contrast
with the direct effect ofpervanadate previously observed in
the fraction of UMRl06 cells [18].
The effectiveness ofthe three vanadium derivatives at
maximum dose was compared. Vanadyl (25 pM) and per-
vanadate (25 trM), which showed the maximum stimulation
in cell proliferation, were 134 t 3 and 135 t 4% above ba-
sal, respectively, whereas vanadate (25 pM) increased oste-
oblast-like cell growth by I I 9 t 2oA over basal (p < 0.00 I ).
These results show that vanadyl and pervanadate are stronger
stimulators than vanadate.
Discussion
The present study was undertaken to examine the effects of
different vanadium compounds on osteoblastJike cell pro-
I i ferati on and di fferentiation in vi tro. YanVdate i ncreases cell
growth in a biphasic manner. This pattern has been previously
shown by Canalis in culture rat calvaria Il], Kato et al in
rabbit costal chondrocyte culture [2] and Davidai et al in
MC3T3-El cells I l6]. In all the cases, the higher concentra-
tions tested clearly inhibited cell proliferation. Vanadyl and
pervanadate seemed to be better mitogens since they did not
inhibit cell growth in osteoblast-like UMRl06 cells and also
showed a more potent effect than vanadate.
These vanadium compounds behave like growth factors:
they stimulate cellular proliferation in a proportion similar
150
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in osteoblast-like UMRl06 cells. Data are expressed as 7o over basal and
+ EDTA
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Cells were incubated in DMEM plus different concentmtions of vanadate
aI37'C/24 h. Alkaline phosphatase (ALP) in the cell extract was assayed
in the absence or presence of 25 ¡rM EDTA: basal activities were 2'13 + 14
and 306 r 32 nmol pNP/min.mg protein, respectively. Results are expressed
as 7o over basal, mean a SEM (n = 6). p values vs their respective basal
were: +p < 0.05; ++p < 0.02; #p < 0.002; *#p < 0.001. Differences found
between the assay in the presence and in the absence of EDTA, were not
significant.
shows that vanadyl stimulated cell proliferation at all the used
concentrations and did not inhibit cell growth under these
conditions. On the other hand, vanadyl had no statistically
significant effect upon cell differentiation as can be seen in
the results ofthe alkaline phosphatase activity assay (Fig. 3B).
Pervanadate has been proved to be a more potent insulin-
mimetic agent 117,271. Fig.4A shows a dose-responsive
effect of this vanadium derivative. Similarto vanadate action,
pervanadate statistically increased cell proliferation at 5-25
pM. Higher concentrations did not affect the growth of the
osteoblast-like cells. As in the case ofvanadyl, pervanadate
150
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Fig. 3. Effect of vanadyl on cell proliferation (A) and dilferentiation (B)
indicate the mean * SEM (n = 9). p values vs basal: *p < 0.02, #p < 0.001.
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Fig. 4. Effect ofpervanadate on cell proliferation (A) and differentiation (B) in osteoblast-like UMRl06 cells. Data are expressed as Zo over basal and
indicate the mean + SEM (n = 9). p values vs basal: *p < 0.02, #p < 0.001.
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to insulin and IGF-I (Table l). The UMRl06 cells possess
binding sites for insulin and IGF-I, but at the doses used for
insulin, the latter probably stimulates cell proliferation
through Type-l IGF receptor (unpublished observations).
These receptors became phosphorylated upon binding the
cognate hormone [28]. Since vanadate has been postulated
to specifically inhibit PTPases, it could regulate cell growth
by enhancing insulin or IGF autophosphorylation. In adipose
tissue it has been shown that vanadate stimulates glucose
metabolism by a mechanism otherthan autophosphorylation
ofthe insulin receptor [17]. Thus, vanadate could not pro-
duce additional activation of insulin effects in those cells. On
the other hand, pervanadate was able to potentiate the hor-
mone effect in adipocytes by increasing the autophos-
phorylation of insulin receptors [17]. We have previously
shown [l8] that UMRl06 cells have a cytosolic alkaline
phosphatase, partially characterized as a PTPase. This en-
zyme was directly inhibited in the in vitro assay by vanadium
derivatives. Thus, the inhibition of a specific PTPase is likely
to play a role in the modulation of UMR106 cell growth.
Pervanadate and vanadyl seem to be less important in the
control ofcell differentiation, as has been demonstrated by
the ALP assay. It is known that pervanadate is unstable and
spontaneously decomposes to vanadate [27].Although we did
not test this process during our cell incubation period, the
absence ofpervanadate effect on cell differentiation (Fig. 48)
suggests that not enough vanadate was generated to inhibit
cell differentiation (it has to be at least >_2.5 ¡tM, Fig. 2B).
On the other hand, we have previously shown [18] that both
vanadyl and pervanadate directly inhibit a partially charac-
terized citosolic PTPase in UMRl06 cells. Thus, this mecha-
nism, although not directly tested by the authors, would
partially explain the vanadium compound stimulatory effect
on cell proliferation. Vanadate was the only compound which
inhibited cell differentiation at mitogenic doses. This effect
was not a direct in vitro inhibition of alkaline phosphatase
activity but rather a decrease in the enzyme amount. Consid-
ering that the cell monolayer was resuspended in 0.5 ml solu-
bilization solution, a rough estimate of vanadate concen-
tration in the extract suggests that it should be diluted to the
extent that it does not directly affect the alkaline phosphatase
activity. The experiment performed in the presence of EDTA,
in a concentration estimated to totally complex free vanad-
ate 126l did not blunt out the vanadium effect on cell differ-
entiation. A similar effect, induced by insulin, was observed
in Ros 1712.8 rat osteosarcoma cells [7]. However, Canalis
et al. foundthat treatment with vanadate did not stimulate ALP
activity in a calvaria culture I I ]. This enzyme was inhibited
in bone exposed to I mM vanadate, a dose which caused
inhibition of thymidine incorporation into DNA. In our study
the higher doses of vanadate (> 75 pM) activated alkaline
phosphatase, an effect not observed in the presence ofother
vanadium derivatives. This could be a compensatory effect
ofosteoblast-like cells, under a condition ofdecreased cell
proliferation [22]. Those studies and the present one suggest
that pervanadate as well as vanadyl can regulate cell prolif-
eration without the cell growth inhibitory effect observed with
vanadate. Whether these are tissue-specific effects of vana-
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dium derivatives or general effects on many cell types is
currently under investigation in our laboratory.
In the last years, new derivatives ofvanadate having insu-
lin-mimetic action have been searched for and they seem to
be promisory as regards growth promoting effects. Thus,
these compounds are potentially pharmacological tools in the
control of metabolic states of insulin resistence and patho-
logies with bone growth alterations.
Acknowledgements
The authors would like to thank Miss Nyria Fenoglio for
reviewing the manuscript language. AMC is member of the
Carrera del Investigador, CICPBA,Argentina; SBE is mem-
ber of the Carrera del Investigador, CONICET, Argentina.
This work was supported by grants from: Facultad de
Ciencias Exactas, UNLP; Universidad Nacional de La Plata,
Argentina and The Third World Academy of Sciences.
References
l. Compston JE: Osteoporosis. Clin Endocrinol 33: 653-{82, 1990
2. Marcus R: Skeletal aging. Understanding the functional and structural
bases ofosteoporosis. Trends Endocrinol Metab 2: 53-58, l99l
3. Cooper C, Melton J II: Epidemiology of osteoporosis. Trends
Endocrinol Metab. 3: 22+-229,1992
4. Farley JR, Tarbaux N, Murphy LA, Masuda I Baylink DJ: In vitro
evidence that bone formation may be coupled to bone resorption by
release of mitogen(s) from resorbing bone. MetabolismS6:314-321,
I 987
5. Baylink DJ, Finkelman RD, Mohan S: Growth factors to stimulate
bone formation. J Bone Min Res 8, Supp 2: 5565-5572, 1993
6. Centrella M, Canalis E: Local regulators of skeletal growth: a
perspective. Endocr Rev 6: 544-551, 1985
7. Levy JR, Murray E, Manolagas S, Olefky JM: Demonstration of
insulin receptors and modulation of alkaline phosphatase activity by
insulin in rat osteoblastic cells. Endocrinology I l9: l'18d1792, 1986
8. Mohan S, Baylink DJ: The role of insulinJike growth factor-ll in the
coupling of bone formation to resorption. In: E.M. Spencer (ed.).
Modem Concepts in lnsulin-like Growth Factors. Elsevier, NewYork,
1991, pp. 169-184
9. Hashizume M, Yamaguchi M: Stimulatory effect of p-alanyl-L-
histidinato zinc on cell proliferation is dependent on protein synthesis
in osteoblastic MC3T3-E I cells. Mol Cell Biochem 122: 59-64, 1993
10. Nielsen FH, Uthus EC: The essentiality and metabolism of
vanadium.ln: N.D. Chasteen (ed.). Vanadium in Biological Systems.
Kluwer Academic Publishers, Netherlands, 1990, pp. 5l-{2
I l. Canalis E: Effect of sodium vanadate on deoxyribonucleic acid and
protein synthesis in cultured rat calvariae. Endocrinology I l6:
855-{62, t985
[ 2. Kato Y, Iwamoto M, Koke T, Suzuki F: Effect of vanadate on cartilage-
matrix proteoglycan synthesis in rabbit costal chondrocyte cultures.
J Cell Biol 104:3ll-319, 1987
Shechter Y Amir S, Meyerovitch J: The insulin-like merabolic effects
ofvanadate: possible implications to the future care ofdiabetes. Diab
Nutr Metab l: l-5, 1988
Fantus IG, Kadota S, Deragon G, Foster B, Posner BI: Pervanadate
[Peroxide(s) of vanadate] mimics insulin action in rat adipocytes via
activation of the insulin receptor tyrosine kinase. Biochemistry 28:
8864-{871, r989
Trudel S, Paquet MR, Grinstein S: Mechanism of vanadate-induced
activation of tyrosine phosphorylation and of the respiratory burst in
HL60 cells. Role of reduced oxygen metabolites. Biochem J 27ó:
ól l-{19, l99t
Davidai C, Lee A, Schuartz I, Hazum E: PDGF induces tyrosine
phosphorylation in osteoblast-like cells: relevance to mitogenesis.
Am J Physiol 263: E205-8209,1992
Shisheva A, Shechter Y: Mechanism of pervanadate stimulation and
potentiation of insulin-activated glucose transport in rat ádipocytes.
Dissociation from vanadate effect. Endocrinology 133: 1562-1568,
r 993
Cortizo AM, Salice VC, Etcheverry SB: Vanadium compounds: their
action on alkaline phosphatase activity. Biological Trace Element
Research 4l : 331-339, 1994
Partridge NC, Alcorn D, Michelangeli VP, Ryan G, Martin TJ:
Morphological and biochemical characterization of lour clonal
osteogenic sarcoma cell lines of rat origin. Cancer Res 43: 4308--43 I 4,
r 983
Okajima T, Nakamura K, Zhang H, Ling N, Tanabe T, Yasuda T,
Rosenfeld RC: Sensitive colorimetric bioassays for insulin-like
growth factor (lGF) stimulation of cell proliferation and glucose
consumption: use in studies of IGF analogs. Endocrinology 130:
2201,-22t2,1992
Bradford M: Rapid and sensitive method for quantitation of
microgram quantities of protein utilizing the principle of protein-
dye binding. Anal Biochem 72:248-254,1976
Stein GS, Lian JB: Molecular mechanism mediating proliferation/
differentiation interrelationships during progressive development of
the osteoblast phenotype. Endocrine Rev l4: 42U42, 1993
Schmid CH, Steiner TH, Froesch ER: Insulin-like growth factors
stimulate synthesis olnucleic acids and glycogen in cultured calvaria
cells. CalcifTissue lnt 35: 578-585, 1983
Bonewald LF, Schwartz Z, Swain LD, Ramirez Y Poser J, Boyan
BD: Stimulation of plasma membrane and matrix vesicle enzyme
activity by transforming growth factor-p in osteosarcoma cell cultures.
J Cell Physiol 145: 200-206, 1990
Zhang RW, Simmons DJ, Crowther RS, Mohan S, Baylink DJ:
Contribution of marrow stroma cells to the regulation of osteoblast
proliferation in rats: evidence for the involvement of insulin-like
growth-factors. Bone and Mineral l3:201-215, l99l
Crans DC, Bunch RL, Theisen LA: lnteraction of trace levels of
vanadium (lV) and vanadium (V) in biological systems. J Am Chem
Soc I I l: 7597-:7607, 1989
Kadota S, Fantus IG, Deragon C, Guyda HJ, Hersh B, Posner BI:
Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent
which activates the insulin receptor kinases. Biochem Biophys Res
Comm 147: 259-263,1987
Yarden Y, Ullrich A: Growth factor receptor fyrosine kinases. Ann
Rev Biochem 57: 441478, 1988
13.
t4.
15.
16.
17.
18.
t9
20
2t.
22
23.
24.
25
26.
?7
28.
